Materialise NV
NASDAQ:MTLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Materialise NV
NASDAQ:MTLS
|
BE |
|
CoStar Group Inc
NASDAQ:CSGP
|
US |
|
Nedbank Group Ltd
OTC:NDBKF
|
ZA |
|
Nongfu Spring Co Ltd
F:7NF
|
CN |
|
Abeona Therapeutics Inc
F:PCJ
|
US |
|
Coastal Financial Corp (EVERETT)
F:1VD
|
US |
|
A
|
Arista Networks Inc
F:117
|
US |
|
S
|
Skechers USA Inc
XBER:SKAA
|
US |
|
W
|
Wynn Resorts Ltd
XHAM:WYR
|
US |
|
U
|
Unilever PLC
XHAM:UNV0
|
UK |
|
P
|
Pernod Ricard SA
XETRA:PER
|
FR |
Materialise NV
Materialise NV is a 3D printing company that sits between the digital design world and the factory floor. It builds software that helps engineers prepare parts for additive manufacturing, and it also prints finished parts itself for customers that need prototypes, custom parts, or low-volume production. In simple terms, it helps turn a digital file into a real object through 3D printing. The company sells mainly to industrial manufacturers, healthcare providers, and medical device companies. Its revenue comes from software subscriptions and licenses, plus fees for printing and finishing parts in its own production facilities. A separate part of the business serves hospitals and surgeons with patient-specific medical tools, implants, and planning software used for procedures. What makes Materialise different is that it does both sides of the 3D printing process: it writes the software that plans the print job and it runs the machines that make the parts. That gives it a useful role in the value chain, especially in industries where custom geometry, precision, and small production runs matter more than mass production.
Materialise NV is a 3D printing company that sits between the digital design world and the factory floor. It builds software that helps engineers prepare parts for additive manufacturing, and it also prints finished parts itself for customers that need prototypes, custom parts, or low-volume production. In simple terms, it helps turn a digital file into a real object through 3D printing.
The company sells mainly to industrial manufacturers, healthcare providers, and medical device companies. Its revenue comes from software subscriptions and licenses, plus fees for printing and finishing parts in its own production facilities. A separate part of the business serves hospitals and surgeons with patient-specific medical tools, implants, and planning software used for procedures.
What makes Materialise different is that it does both sides of the 3D printing process: it writes the software that plans the print job and it runs the machines that make the parts. That gives it a useful role in the value chain, especially in industries where custom geometry, precision, and small production runs matter more than mass production.
Revenue: Materialise reported first-quarter revenue of EUR 66.3 million, stable year on year despite foreign exchange headwinds and macro uncertainty.
Profitability: Gross profit rose to EUR 37.9 million and gross margin improved to more than 57%; adjusted EBIT climbed to EUR 2.5 million from EUR 0.6 million a year ago.
Portfolio moves: The company announced plans to transfer its eyewear business to management, following the earlier agreement to do the same with RapidFit, so it can focus capital and leadership on core segments.
Medical strength: Medical revenue grew 7% to EUR 33.2 million, helped by Medical Devices, while management said the segment’s long-term growth and margin profile remains healthy despite seasonal and FX effects.
Outlook: Full-year 2026 guidance was reaffirmed at EUR 273 million to EUR 283 million for revenue and EUR 10 million to EUR 12 million for adjusted EBIT, even after the divestments.
Cash flow: Free cash flow was positive, cash rose to EUR 133 million, gross debt fell to EUR 60.1 million, and net cash increased to EUR 72.8 million.
